-
Researchers determine how a specific protein regulates tumor growth
worldpharmanews
January 03, 2020
Immune checkpoints are surface proteins that cancer cells use to evade immune response. These surface proteins are critical for cancer cell growth and drugs targeting these proteins have ...
-
High-tech method for uniquely targeted gene therapy developed
worldpharmanews
December 17, 2019
Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that ...
-
Free tool simplifies cancer research
worldpharmanews
December 17, 2019
Every cell contains a vast number of proteins, each of which has a specific function, for example as a receptor for another molecule or an enzyme that catalyses chemical reactions.
-
Biomedical engineers develop system that allows for real-time observations of individual cells in colon
Expresspharma
December 16, 2019
Researchers expect the procedure to allow new investigations into the digestive system’s microbiome as well as the causes of diseases like...
-
Sartorius Expands Cell Culture Media Capabilities
contractpharma
December 12, 2019
Sartorius has signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries.
-
US researchers develop CAR T cell therapy for cancer
pharmaceutical-technology
September 27, 2019
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.
-
Cause of antibiotic resistance identified
worldpharmanews
September 27, 2019
Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patients with recurring urinary tract infections ...
-
GenScript Partners with Harvard to Develop Ultra-safe Cells Resistant to Natural Viruses
contractpharma
September 24, 2019
GenScript, a gene synthesis provider, will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project ...
-
CAR T for Large Tumors: The Next Frontier?
contractpharma
September 12, 2019
Traditional cancer treatments tend to be unprecise, the effect of which both healthy and cancerous cells are destroyed. Chemotherapy or radiation are like the military carpet bombing an area...
-
Personalised cell therapy developer Achilles closes £100m round
pharmaceutical-technology
September 05, 2019
UK-based Achilles Therapeutics has announced the closing of its £100m Series B financing round, which was led by new investor RA Capital Management and founding investor Syncona.